Cancer Types: Difference between revisions
| [unchecked revision] | [unchecked revision] |
| Line 824: | Line 824: | ||
:Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA | :Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA | ||
:AML with t(9;11)(p22;q23); MLLT3-MLL | :AML with t(9;11)(p22;q23); MLLT3-MLL | ||
:AML with t(6;9)(p23;q34); DEK- | :AML with t(6;9)(p23;q34); DEK-NUP214 | ||
:AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1 | |||
:AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1 | :AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1 | ||
:AML with mutated NPM1 | :AML with mutated NPM1 | ||